相似文献
1
Treatment of colorectal metastases: surgery, cryotherapy, or radiofrequency ablation.
Gut. 2002 Jan;50(1):1-5. doi: 10.1136/gut.50.1.1.
2
[Modalities and feasibility of treatment by local destruction of hepatic matastases (TLDHM)].
Gastroenterol Clin Biol. 2003 Mar;27 Spec No 2:B16-7, B80-7.
3
[Can initially non-respectable hepatic metastases be made resectable?].
Gastroenterol Clin Biol. 2003 Mar;27 Spec No 2:B18-9, B88-104.
4
Local Ablation for Solid Tumor Liver Metastases: Techniques and Treatment Efficacy.
Cancer Control. 2016 Jan;23(1):30-5. doi: 10.1177/107327481602300106.
5
Radiofrequency ablation for colorectal liver metastases.
J Visc Surg. 2014 Apr;151 Suppl 1:S33-44. doi: 10.1016/j.jviscsurg.2013.12.005. Epub 2014 Feb 28.
6
Comparison between local ablative therapy and chemotherapy for non-resectable colorectal liver metastases: a prospective study.
Ann Surg Oncol. 2007 Mar;14(3):1161-9. doi: 10.1245/s10434-006-9312-5. Epub 2006 Dec 31.
7
Percutaneous radiofrequency ablation of liver metastases in potential candidates for resection: the "test-of-time" approach.
Cancer. 2003 Nov 15;98(10):2303-4; author reply 2304-5. doi: 10.1002/cncr.11782.
8
Management of liver metastases from colorectal cancer.
Oncology (Williston Park). 2006 Sep;20(10):1161-76, 1179; discussion 1179-80, 1185-6.
9
[Recent advances in the case management of colorectal cancer liver metastases].
Bull Acad Natl Med. 2003;187(5):899-904.
10
Local radiofrequency ablation techniques for liver metastases of colorectal cancer.
Crit Rev Oncol Hematol. 2007 May;62(2):153-63. doi: 10.1016/j.critrevonc.2006.12.001. Epub 2007 Feb 20.
引用本文的文献
1
Characteristics of successful expansion of tumor-infiltrating lymphocytes from colorectal cancer liver metastasis.
Sci Rep. 2025 Jan 10;15(1):1639. doi: 10.1038/s41598-025-85892-5.
2
Unlocking the Potential of RNA Nanoparticles: A Breakthrough Approach to Overcoming Challenges in Colon Cancer Treatment.
Curr Pharm Biotechnol. 2025;26(7):992-1013. doi: 10.2174/0113892010285554240303160500.
3
Small Particle DEBIRI TACE as Salvage Therapy in Patients with Liver Dominant Colorectal Cancer Metastasis: Retrospective Analysis of Safety and Outcomes.
Curr Oncol. 2022 Jan 6;29(1):209-220. doi: 10.3390/curroncol29010020.
4
Surgical margin clearance and extended chemotherapy defines survival for synchronous oligometastatic liver lesions of the ductal adenocarcinoma of the pancreas.
Int J Clin Oncol. 2021 Oct;26(10):1911-1921. doi: 10.1007/s10147-021-01961-5. Epub 2021 Jun 16.
5
RNA-based therapeutics for colorectal cancer: Updates and future directions.
Pharmacol Res. 2020 Feb;152:104550. doi: 10.1016/j.phrs.2019.104550. Epub 2019 Dec 19.
6
Surgery for Recurrent Pancreatic Cancer: Is It Effective?
Cancers (Basel). 2019 Jul 16;11(7):991. doi: 10.3390/cancers11070991.
7
Proposal of Two Prognostic Models for the Prediction of 10-Year Survival after Liver Resection for Colorectal Metastases.
HPB Surg. 2018 Oct 21;2018:5618581. doi: 10.1155/2018/5618581. eCollection 2018.
8
Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal Carcinoma.
Mediators Inflamm. 2018 Apr 4;2018:8031328. doi: 10.1155/2018/8031328. eCollection 2018.
9
Does primary tumor location impact the prognosis of colorectal liver metastases patients after microwave ablation? - Lessons from 10 years' experience.
Oncotarget. 2017 Jun 28;8(59):100791-100800. doi: 10.18632/oncotarget.18764. eCollection 2017 Nov 21.
10
Extracts of Zuo Jin Wan, a traditional Chinese medicine, phenocopies 5-HTR1D antagonist in attenuating Wnt/β-catenin signaling in colorectal cancer cells.
BMC Complement Altern Med. 2017 Nov 28;17(1):506. doi: 10.1186/s12906-017-2006-7.
本文引用的文献
1
Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer.
N Engl J Med. 2001 Jul 12;345(2):144-5; author reply 146. doi: 10.1056/NEJM200107123450213.
2
Cryosurgery for colorectal liver metastases.
Hepatogastroenterology. 2001 Mar-Apr;48(38):323-4.
3
Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.
Hepatology. 2001 May;33(5):1124-9. doi: 10.1053/jhep.2001.24233.
4
Interstitial laser thermotherapy in the treatment of colorectal liver metastases.
J Surg Oncol. 2001 Jan;76(1):73-81. doi: 10.1002/1096-9098(200101)76:1<73::aid-jso1014>3.0.co;2-0.
5
Locoregional management of hepatocellular carcinoma. Surgical and ablation therapies.
Clin Liver Dis. 2001 Feb;5(1):161-73. doi: 10.1016/s1089-3261(05)70159-8.
6
Usefulness of intraoperative radiofrequency thermoablation of liver tumours associated or not with hepatectomy.
Eur J Surg Oncol. 2000 Dec;26(8):763-9. doi: 10.1053/ejso.2000.1000.
7
Radiofrequency ablation of 231 unresectable hepatic tumors: indications, limitations, and complications.
Ann Surg Oncol. 2000 Sep;7(8):593-600. doi: 10.1007/BF02725339.
8
Palliative chemotherapy for advanced colorectal cancer: systematic review and meta-analysis. Colorectal Cancer Collaborative Group.
BMJ. 2000 Sep 2;321(7260):531-5. doi: 10.1136/bmj.321.7260.531.
9
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.
J Clin Oncol. 2000 Aug;18(16):2938-47. doi: 10.1200/JCO.2000.18.16.2938.
10
Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm.
Arch Surg. 2000 Jun;135(6):657-62; discussion 662-4. doi: 10.1001/archsurg.135.6.657.
Zotero 插件